42 results
Page 2 of 3
6-K
EX-4.2
bbui3
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
5y81fjq
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-4.1
g9tughd3hudpar43
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
6-K
EX-1.1
n9l22oeom
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
w99urnfk
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
gg1eemjhww3 jkj
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-99.2
jauzstgpp6j3xae9l9
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.2
939ufib
26 Jul 19
Condensed Consolidated Financial Statements
4:32pm
424B3
hti3mrexc ccb3
10 Jul 19
Prospectus supplement
8:18am
F-3
xp6 xlsmfxbsuyohpy07
28 Jun 19
Shelf registration (foreign)
9:48am
6-K
EX-99.2
sethy3
20 May 19
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
gexokbnzze1
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.4
5gcjewa6
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
uz71ti91e48ep3
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
kzt52wzeqxyadwa745i
19 Nov 18
Agreement and Plan of Merger
4:34pm
20-F
0cd50xd8vzh
31 Mar 15
Annual report (foreign)
12:00am